Type 2 Diabetes

If you are a Type 2 Diabetic who is currently using oral antidiabetics and has a HbA1c between 7.0% and 10.0%, you may be eligible to participate in this clinical research study.  The study is designed to improve future treatment options for diabetes patients.

Study duration is approximately 8 months and involves about 6 visits a year to our clinic.

Basic Entry Qualifications:

 *  Male or Female, age 18 or older

 *  Type 2 Diabetic (confirmed diagnosis)   

 *  HbA1c levels between 7.05 - 10.0%.  The COR medical team will help you determine this number.

Qualifying participants receive study-related examinations and investigational drug at no charge.                    Call (405) 272-8481 or complete the form below.

Your First & Last Name
Birthdate (MM/DD/YY)
Seeking information on a study for (choose one)	Cardiovascular Health Type 2 Diabetes Diabetes w/ Heart/Blood Vessel Risk Factors DiabetesLow SodiumRespiratory HealthMigrainesKidney DiseaseBlood Clots/DVTChelation TherapyMultiple Health Areas
May we (COR) have your permission to leave you voice messages regarding particular studies?	YESNO
Phone number (best for daytime)
Email address
Image Verification Please enter the text from the image: [ Refresh Image ] [ What's This? ]

Powered byEMF Form Builder